In the Saturday, June 21, symposium, Emerging Non-Peptide, Small Molecule GLP-1 Receptor AgonistsCan They Become Players?, experts explored the promising new frontier of non-peptide GLP-1 RAs, reviewing design considerations for small molecules in the context of GLP-1 receptor structure and function, the rapidly expanding clinical development pipeline for non-peptide agonists, and encouraging clinical evidence
Mitochondria impact brain function and cognition
van der Plas E, Meij-de Vries A, Goede J, et al
Frequently Asked Questions Whats the difference between Semaglutide and Tirzepatide
Experimente ambos os mtodos e veja o que funciona melhor para voc
The use the peptide Ac-Nle-c c/o(-Asp-His-D-Phe-Arg-Trp-Lys)-OH in the manufacture of a medicament for intranasal administration for use in the treatment of erectile dysfunction in a male, wherein the peptide Ac-Nle-cyc/o(-Asp-His-D-Phe-Arg-Trp-Lys)-OH increases cGMP levels to an amount sufficient to produce an erection sufficient for sexual intercourse when the peptide Ac-Nle-cyc/o(-Asp-His-D-Phe-Arg-Trp-Lys)-OH is administered at a sub-therapeutic dose and administered subsequent to a sub-therapeutic dose of a PDE-5 inhibitor